Form 4: MapLight Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Jonathan Gillis, CAO and Interim CFO of MapLight Therapeutics, Inc., sold 10,167 shares of common stock on October 15, 2026 for $8.08 per share.
Summary
- Open-market sale: disposed of 10,167 Voting Common Stock at $8.08 ($82,149) on October 15, 2026; holds 142,315 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $82,149 of stock on the open market.
Insider Transactions
Jonathan Gillis — Officer (CAO and Interim CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Open-market sale | Voting Common Stock | 10,167 | $8 | $82.1K | 142,315 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Open-market sale (10,167 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Jonathan Gillis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.